Jointechlabs – a leader in point-of-care regenerative medicine therapies – announced that the U.S. Food and Drug Administration (FDA) cleared the company’s MiniTC™ for point-of-care fat tissue processing designed to obtain microfat

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In